The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases

The Oncologist
Fabio Ynoe MoraesYoshiya Yamada

Abstract

Brain metastases are the most common intracranial malignancy. Many approaches, including radiation therapy, surgery, and cytotoxic chemotherapy, have been used to treat patients with brain metastases depending on the patient's disease burden and symptoms. However, stereotactic surgery (SRS) has revolutionized local treatment of brain metastases. Likewise, targeted therapies, including small-molecule inhibitors and monoclonal antibodies that target cancer cell metabolism or angiogenesis, have transformed managing systemic disease. Prospective data on combining these treatments for synergistic effect are limited, but early data show favorable safety and efficacy profiles. The combination of SRS and targeted therapy will further individualize treatment, potentially obviating the need for cytotoxic chemotherapy or whole-brain radiation. There is a great need to pursue research into these exciting modalities and novel combinations to further improve the treatment of patients with brain metastases. This article discusses reported and ongoing clinical trials assessing the safety and efficacy of targeted therapy during SRS. Treatment of patients with brain metastases requires a multidisciplinary approach. Stereotactic radiosurgery is i...Continue Reading

References

Jan 4, 1995·Journal of the National Cancer Institute·E AlexanderJ S Loeffler
Mar 1, 1994·International Journal of Radiation Oncology, Biology, Physics·J C FlickingerP K Sneed
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A PirzkallM Wannenmacher
Jun 23, 2000·International Journal of Radiation Oncology, Biology, Physics·L E GasparW Curran
Aug 30, 2003·Oncogene·Richard Kolesnick, Zvi Fuks
Oct 31, 2003·Cancer Treatment Reviews·Roy A Patchell
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K M FifeJ F Thompson
Aug 16, 2005·Clinical Colorectal Cancer·Mark L SundermeyerSteven J Cohen
Aug 16, 2005·Cancer Cell·Zvi Fuks, Richard Kolesnick
Dec 28, 2005·Seminars in Radiation Oncology·George D WilsonPaul M Harari
Feb 10, 2006·The New England Journal of Medicine·James A BonnerK Kian Ang
Feb 12, 2008·International Journal of Radiation Oncology, Biology, Physics·Clint ParkRobert D Timmerman
Mar 11, 2010·Melanoma Research·Noël E C SchartzCéleste Lebbé
Mar 26, 2010·The New England Journal of Medicine·John H Suh
Nov 19, 2010·Current Oncology Reports·Eudocia C Quant, Patrick Y Wen
Dec 21, 2011·Technology in Cancer Research & Treatment·E H BalagamwalaJ H Suh
Jan 4, 2012·Acta Neuropathologica·Matthias PreusserAndreas von Deimling
Mar 30, 2012·The Lancet Oncology·Kim MargolinF Stephen Hodi
Jun 19, 2012·Journal of Neurosurgery·Jonathan P S KniselyVeronica L S Chiang
Jul 17, 2012·Thyroid : Official Journal of the American Thyroid Association·Yan ShenLibo Chen
Jan 8, 2013·Journal of the National Cancer Institute·Silvia C Formenti, Sandra Demaria
Jan 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James W WelshBaldassarre Stea
Apr 13, 2013·Journal of Neuro-oncology·Ashwatha NarayanaAnna C Pavlick
May 7, 2013·International Journal of Radiation Oncology, Biology, Physics·Reshma Jagsi, Lynn D Wilson
Aug 10, 2013·Journal of Neuro-oncology·Christopher P DeibertDouglas Kondziolka
Dec 4, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Reinhard DummerJeannine D Rinderknecht
Dec 20, 2013·Current Treatment Options in Neurology·Nancy U Lin
Jan 3, 2014·Case Reports in Oncological Medicine·Jacob RuzevickMichael Lim
Jan 10, 2014·Cancer Medicine·Ann W SilkChristopher D Lao
Jan 15, 2014·International Journal of Radiation Oncology, Biology, Physics·J Martin BrownDavid J Brenner
Apr 1, 2014·International Journal of Radiation Oncology, Biology, Physics·Naamit K GerberAbraham J Wu

❮ Previous
Next ❯

Citations

Feb 9, 2016·World Neurosurgery·Amir HadannyTal Shahar
May 27, 2016·Current Treatment Options in Neurology·Zarmeneh Aly, David M Peereboom
Oct 23, 2016·Clinical Lung Cancer·Yuri SheikineDaniel B Costa
Oct 18, 2016·Current Opinion in Oncology·Roberta RudàRiccardo Soffietti
Dec 5, 2017·Continuum : Lifelong Learning in Neurology·Amy A Pruitt
Sep 15, 2018·Technology in Cancer Research & Treatment·Muhammad KhanYawei Yuan
Oct 16, 2020·World Neurosurgery·Stephen G BowdenSeunggu J Han
Mar 16, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Fabio Y MoraesDavid B Shultz
Apr 7, 2021·Translational Neuroscience·Zihuang LiMeili Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

International Journal of Clinical Oncology
Takamitsu Fujimaki
Current Treatment Options in Neurology
April F Eichler, Scott R Plotkin
Current Neurology and Neuroscience Reports
Harry C BrastianosPriscilla K Brastianos
© 2022 Meta ULC. All rights reserved